PHARMACEUTICALS
    8.
    发明专利

    公开(公告)号:JPH03167120A

    公开(公告)日:1991-07-19

    申请号:JP23599790

    申请日:1990-09-07

    申请人: GLAXO GROUP LTD

    摘要: PURPOSE: To obtain a pharmacological composition capable of improving treating effects on respiratory diseases, especially an action time, by combining a salmeterol (bronchodilator) with fluticasone propionate (antiinflammatory agent) in a state suitable for administration by inhalation. CONSTITUTION: This composition comprises (a) a salmeterol and/or its physiologically permissible salt, preferably 1-hydroxy-2-naphthalenecarboxylate and (b) fluticasone propionate in effective amounts of 25-100μg of the component (a) and 5-1,000μg of the component (b) in a combined preparation for simultaneous, continuous or separative administration in treatment of respiratory diseases and has extremely higher efficiency and bronchodilation action time than a known combination. Since the number of times of administration can be reduced to twice daily, the composition has merits of treating asthma, especially asthma at night. The composition is also provided in the form of a measured administration inhalator or a measured powder composition.